CS252340B1 - 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative - Google Patents

4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative Download PDF

Info

Publication number
CS252340B1
CS252340B1 CS863351A CS335186A CS252340B1 CS 252340 B1 CS252340 B1 CS 252340B1 CS 863351 A CS863351 A CS 863351A CS 335186 A CS335186 A CS 335186A CS 252340 B1 CS252340 B1 CS 252340B1
Authority
CS
Czechoslovakia
Prior art keywords
methyl
pyrazolo
quinoline
chloro
methoxy
Prior art date
Application number
CS863351A
Other languages
Czech (cs)
Other versions
CS335186A1 (en
Inventor
Viktor Zikan
Stanislav Radl
Original Assignee
Viktor Zikan
Stanislav Radl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viktor Zikan, Stanislav Radl filed Critical Viktor Zikan
Priority to CS863351A priority Critical patent/CS252340B1/en
Publication of CS335186A1 publication Critical patent/CS335186A1/en
Publication of CS252340B1 publication Critical patent/CS252340B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

ŘeSení se týká 4-chlor-6methoxy- -3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N -methylderivétu obecného vzorce I Cl R kde R je atom vodíku nebo methylskupina. Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.The solution relates to 4-chloro-6methoxy-3-methyl-1H-pyrazolo[3,4-b]quinoline and its N-methyl derivative of the general formula I Cl R where R is a hydrogen atom or a methyl group. These new, previously undescribed substances are useful as intermediates for the preparation of substances exhibiting significant biological effects, in particular antiviral and antitumor effects.

Description

ŘeSení se týká 4-chlor-6methoxy-3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N -methylderivétu obecného vzorce IThe invention relates to 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline and its N-methyl derivative of the general formula I

ClCl

R kde R je atom vodíku nebo methylskupina. Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.Wherein R is hydrogen or methyl. These novel substances, which have not been described yet, are useful as intermediates for the preparation of substances having significant biological effects, in particular antiviral and antitumor activity.

Vynález ae týká 4-chlor-6-meth9xy-3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N’-methylderivátu obecného vzorce IThe invention relates to 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline and its N'-methyl derivative of the formula I

kde H je atom vodíku nebo methylakupina.wherein H is hydrogen or methyl.

Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.These novel substances, which have not been described yet, are useful as intermediates for the preparation of substances having significant biological effects, in particular antiviral and antitumor activity.

Sloučeninu obecného vzorce I, kde R je atom vodíku, lze podle vynálezu připravit cyklizací 3-(4-methoxyanilino)-5-methyl-1H-pyrazol-4-karboxylové kyseliny oxidochloridetn fosforečným. Sloučeninu obecného vzorce I, kde H je methylakupina, lze podle vynálezu připrevit methylací sloučeniny obecného vzorce I, kde R je atom vodíku, dimethylsulfátem v přítomnosti práškového hydroxidu draselného v prostředí aprotického rozpouštědle, výhodně v dimethylsulfoxidu, za teploty místnosti.The compound of formula I wherein R is hydrogen may be prepared according to the invention by cyclizing 3- (4-methoxyanilino) -5-methyl-1H-pyrazole-4-carboxylic acid with phosphorous oxychloride. According to the invention, a compound of formula I wherein H is methyl may be prepared by methylating a compound of formula I wherein R is hydrogen with dimethyl sulfate in the presence of powdered potassium hydroxide in an aprotic solvent environment, preferably dimethylsulfoxide, at room temperature.

Způsob přípravy látek je jednoduchý a poskytuje žádané látky v uspokojivých výtěžcích. Bližší podrobnosti vyplývají z. následujících příkladů provedení. Uvedené příklady tento vynélez pouze ilustrují, nikoliv omezují.The process for preparing the substances is simple and provides the desired substances in satisfactory yields. Further details can be found in the following examples. These examples are merely illustrative and not limiting.

PřikladlHe did

4-chlor-6-methoxy-3-raethyl-1H-pyrazolo/3,4-b/chinolin4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline

Směs 3-(4-methoxyenilino)-5-raethyl-1íi-pyrazol-4-karboxylové kyseliny (4,5 g, 18 mmol) a oxidochloridu fosforečného (40 ml) byla vařena pod zpětným chladičem 1 hodinu. Sirupovitý zbytek získaný oddestilování® přebytku oxidochloridu fosforečného byl nalit na led a směs byla zalkalizována 4M roztokem hydroxidu sodného. Po ochlazení byl nerozpustný podíl odsát a promyt vodou. -<rystalizaci z chloroformu bylo získáno 4,25 g (94 ») žlutých krystalů o t.t. 232 až 236 °C.A mixture of 3- (4-methoxyenilino) -5-methyl-1 H -pyrazole-4-carboxylic acid (4.5 g, 18 mmol) and phosphorus pentoxide (40 mL) was refluxed for 1 hour. The syrupy residue obtained by distilling the excess phosphorus pentoxide was poured onto ice and basified with 4M sodium hydroxide solution. After cooling, the insoluble matter was aspirated and washed with water. Crystallization from chloroform gave 4.25 g (94%) of yellow crystals of m.p. Mp 232-236 ° C.

Přiklad 2Example 2

4-chlor-6-methoxy-1,3-dimethyl-1H-pyrazolo/3,4-b/chinolin4-chloro-6-methoxy-1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline

K suspenzi 4-chlor-6-methcxy-3-methyl-1H-pyrazolo/3,4-b/chinolinu (9,9 g, 40 nuaol) v dimethylsulfoxidu (100 ml) byl přidán práškový hydroxid draselný (2,5 g 45 mmol) a směs byla míchána 4 hodiny za teploty místnosti. Potom byl přidán dimethylsulfát (5,6 g, 45 mmol) a směs byla míchána 8 hodin za teploty místnosti. Směs byla vlita do vody, vyloučená látka byla odsáta a promyta vodou. Surový produkt byl čiětěn vakuovou sublimací. Bylo získáno 8,0 g látky (76 ié) o t.t. 128 až 133 °C.To a suspension of 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline (9.9 g, 40 nuaol) in dimethylsulfoxide (100 mL) was added powdered potassium hydroxide (2.5 g). 45 mmol) and the mixture was stirred at room temperature for 4 hours. Dimethyl sulfate (5.6 g, 45 mmol) was then added and the mixture was stirred at room temperature for 8 hours. The mixture was poured into water, the precipitate was filtered off with suction and washed with water. The crude product was clarified by vacuum sublimation. 8.0 g (76%) of m.p. Mp 128-133 ° C.

Claims (1)

PŘEDMĚT VYNÁLEZUSUBJECT OF THE INVENTION 4-ohlor-6-methoxy-3-methyl-1H-pyrazolo/3,4-b/chinolin a jeho N -methylderivát obecného vzorce I4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline and its N-methyl derivative of the formula I CH3OCH 3 O Cl l\T'N'Cl l \ T'N ' -CH, (I), kde R je atom vodíku nebo methylskupina,-CH, (I) wherein R is hydrogen or methyl,
CS863351A 1986-05-08 1986-05-08 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative CS252340B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS863351A CS252340B1 (en) 1986-05-08 1986-05-08 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS863351A CS252340B1 (en) 1986-05-08 1986-05-08 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative

Publications (2)

Publication Number Publication Date
CS335186A1 CS335186A1 (en) 1987-01-15
CS252340B1 true CS252340B1 (en) 1987-08-13

Family

ID=5373293

Family Applications (1)

Application Number Title Priority Date Filing Date
CS863351A CS252340B1 (en) 1986-05-08 1986-05-08 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative

Country Status (1)

Country Link
CS (1) CS252340B1 (en)

Also Published As

Publication number Publication date
CS335186A1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
KR870000441B1 (en) Process for preparing 7- amino 1- cyclopropyl -4- oxo -1,4 - dihydro - naphthridine -3- carboxylic acids
PL192461B1 (en) Method of obtaining 8-methoxy-quinolinocarboxylic acids
NO842684L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLE DERIVATIVES
CA2368815A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
USRE31429E (en) Process for preparation of 9-(dihalobenzyl)adenines
US4072680A (en) Derivatives of pyrazolo[1,5-a]pyrido[3,2-e]pyrimidine
CS252340B1 (en) 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative
KR20020041421A (en) Process for production of naphthyridine-3-carboxylic acid derivatives
HRP20010759A2 (en) Novel synthesis of piperazine ring
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
KR20120100977A (en) Method for the synthesis of 2-thiohistidine and the like
US5321137A (en) Process for the preparation of imidazopyridines
GB2171995A (en) Pharmaceutically active 8-heteroarylthio-5, 6, 7, 8-tetrahydroquinolines
US3929789A (en) Pyrimidinyl acetic acid derivatives and processes for their production
US4031103A (en) 1,8-Naphthyridine compounds
US4060527A (en) Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives
CA1162543A (en) Process for the preparation of apovincaminic acid esters
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
KR840000522B1 (en) Process for preparation of quinoline derivatives
EP0149537B1 (en) Process for the synthesis of aminonitropyridines
CS252341B1 (en) 0.N-substituted 4,9-dihydro-6-hydroxy-1,3-dimathyl-4-oxo-1H-pyrazolo (3,4-b) quinolines
US4080326A (en) Acetic acid derivatives and processes for their production
CS277411B6 (en) Novel esters of beta-carboline-3-carboxylic acids being substituted in position 5 or 6
US4098787A (en) Process for preparation of 9-(dihalobenzyl) adenines
US4137411A (en) Preparation of 2,4-diamino-5-(4-amino-3,5-substituted-benzyl)-pyrimidines